MedicineAll countries · Checked
Foundayo (Orforglipron): Lilly's Weight Loss Pill, Doses and Price
Foundayo is a once-daily tablet that contains orforglipron. The US FDA approved it for weight loss on April 1, 2026, and the UK authorized it on August 10, 2026. US doses run from 0.8 mg to a maximum of 17.2 mg.
Foundayo at a glance
A GLP-1 pill you swallow once a day, with or without food. It is not an injection.
Medicine and makerOrforglipron, Eli Lilly
Dose range0.8 mg start, 17.2 mg maximum
How oftenOnce a day
From the US label. The UK and EU are at different stages, covered below.
Want to know what a month costs?
See the price of each Foundayo dose in the USFor other countries, open Foundayo price by country.
What it isDoseResultsSide effectsHalf-lifeUKEUPriceGenericFAQ
What is Foundayo (orforglipron)?
Foundayo is the brand name and orforglipron is the medicine inside it, so you will see both names in searches.
It switches on the GLP-1 receptor, the same hormone pathway used by Wegovy and Mounjaro, but you take it as a tablet. Other GLP-1 medicines are covered in every GLP-1 drug in one place.
The US label covers losing weight and keeping it off in adults with obesity, or with overweight and at least one weight-related condition, alongside a reduced-calorie diet and more exercise.
Using it with another GLP-1 medicine is not recommended, and safety and effectiveness in children are not established.
Foundayo dose
You start on 0.8 mg once a day and move up only after at least 30 days on each dose.
10.8 mgFrom day 1The starting dose.
22.5 mgFrom day 31After at least 30 days on 0.8 mg.
35.5 mgFrom day 61After at least 30 days on 2.5 mg.
49 mgFrom day 91Next level, based on response and tolerability.
514.5 mgFrom day 121Another level up, by the same rule.
617.2 mgFrom day 151The maximum dose.
The days are the earliest possible. From 9 mg upward, each step depends on how well it works and how well you tolerate it, so not everyone goes to the top.
Take one tablet a day. Swallow it whole, without breaking, crushing or chewing, with or without food.
If you miss a dose, take it as soon as you can and do not double up. After 7 or more missed doses in a row, you restart the climb from a lower dose to keep stomach side effects down.
Taking a strong CYP3A4 inhibitor, a type of interacting medicine, caps the dose at 9 mg, so tell your prescriber about everything else you take.
To plan your own timeline, use the GLP-1 dose schedule tool.
Foundayo weight loss results
The US label reports two 72-week trials. In adults without diabetes, average weight change was −7.4% on 5.5 mg, −8.3% on 9 mg and −11.1% on 17.2 mg, against −2.1% on placebo.
5.5 mg−7.4%9 mg−8.3%17.2 mg−11.1%
Adults with type 2 diabetes lost less: −5.1% on 5.5 mg, −7.0% on 9 mg and −9.6% on 17.2 mg, against −2.5% on placebo.
These are trial averages, not a promise for any one person. Everyone in the trials also ate fewer calories and moved more.
Foundayo side effects
The most common side effects are in the stomach and gut: nausea, constipation, diarrhea, vomiting and indigestion.
Pooling both trials, nausea affected 10% on placebo and 26%, 34% and 35% on 5.5, 9 and 17.2 mg. Vomiting affected 4% on placebo and 13%, 21% and 24%.
Diarrhea affected 11% on placebo and 21%, 23% and 25%. Constipation affected 9% on placebo and 20%, 27% and 24%.
You cannot take Foundayo if you or your family have had medullary thyroid cancer or MEN 2. The US label carries a boxed warning on thyroid C-cell tumors, which were seen in rodents.
If you use the contraceptive pill, the label says to switch to a non-oral method or add a barrier method for 30 days after you start and for 30 days after each dose increase.
How long Foundayo stays in your body
Half of a dose is cleared in about 29 to 49 hours, and blood levels peak 4 to 8 hours after you swallow it. That is why one tablet a day is enough.
Foundayo in the UK
The UK regulator, the MHRA, authorized Foundayo on August 10, 2026, for weight management and for type 2 diabetes. The UK was the first country in Europe to do so.
For weight management the criteria are a BMI of 30 or more, or 27 to under 30 with at least one weight-related condition. Check your own number with the BMI calculator.
It is not currently available on the NHS, and any NHS use will go through NICE first. It is prescription-only, from a registered pharmacy.
Foundayo in the EU
The EMA's CHMP gave a positive opinion on October 15, 2026, recommending approval. The European Commission's final decision is still to come.
The recommended uses are weight management and type 2 diabetes, in the same six tablet strengths as the US.
Foundayo price
The price changes with the country, the dose and how you pay, so it is not quoted here. The US has its own page with the cost of each dose: Foundayo price in the US.
To weigh it against other GLP-1 medicines, try the GLP-1 cost calculator.
Generic Foundayo and similar medicines
Which GLP-1 medicines have a generic is answered in generic GLP-1 medicines.
The other GLP-1 weight-loss pill is the Wegovy pill. Upcoming medicines are tracked in new GLP-1 drugs.
Foundayo FAQ
Are Foundayo and orforglipron the same drug?
Yes. Foundayo is the brand name of the product, and orforglipron is the medicine inside.
Is Foundayo approved for type 2 diabetes?
Yes in the UK. The US label covers weight loss only, and the EU is at the recommendation stage.
What is the highest Foundayo dose?
17.2 mg once a day. No higher dose is approved.
Do I take Foundayo with food?
No. You can take it with or without food. Swallow the tablet whole.
Can I get Foundayo on the NHS?
Not yet. It is licensed in the UK but not currently available on the NHS, and NICE has to assess it first.
Keep reading
Foundayo price in the US: cost of each dose
Wegovy (semaglutide) for weight loss
Mounjaro (tirzepatide) by country
This page follows the US FDA label and UK and EU regulator notices and is updated when they change. See how we check our pages.
Update log
: First published.
Sources
US FDA, Foundayo prescribing information.
MHRA, UK first in Europe to authorise orforglipron.
European Medicines Agency, Foundayo opinion page.
GLP1 Note is an independent information site. Which medicine and dose suit you is for your prescriber to decide.